40
Participants
Start Date
February 29, 2024
Primary Completion Date
November 25, 2024
Study Completion Date
November 25, 2024
Platelet-rich plasma (PRP) combined with human umbilical cord mesenchymal stem cells (huMSCs)
Inject 3mL PRP+huMSCs (5 × 106) into the edge and bottom of the wound, with 0.5 ml at each point and a distance of approximately 1-3 cm between each point. Then, apply autologous PRP gel (PRP+thrombin mixture, 2ml) evenly on the wound, with a thickness of about 2mm
Control group
Standard therapy for patients with stage 3 and 4 stress injury
RECRUITING
Central laboratory, Liaocheng
Liaocheng People's Hospital
OTHER